Sign In
Buy COO
$71.35
-0.780 (-1.08%)
At Close: Nov 17, 2025
Jana Partners push to break up Cooper Cos. could change the stock's outlook
07:59am, Saturday, 15'th Nov 2025
Jana announced a top portfolio position in Cooper and plans to push for strategic alternatives, including a potential combination for its contact lens unit.
Jana Partners Reduces Stake in Mercury Systems Inc.
08:42pm, Friday, 14'th Nov 2025
On November 6, 2025, Jana Partners (Trades, Portfolio) executed a notable reduction in its holdings of Mercury Systems Inc. The firm decreased its position by 9
Jana Partners' Strategic Move: Significant Addition of The Cooper Companies Inc
05:10pm, Friday, 14'th Nov 2025
Exploring Jana Partners (Trades, Portfolio)' Latest 13F Filing and Investment Strategy Jana Partners (Trades, Portfolio) recently submitted the 13F filing for
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025
04:15pm, Tuesday, 04'th Nov 2025
SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results
Michael Benkowitz Sells 22,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:42am, Thursday, 30'th Oct 2025
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) COO Michael Benkowitz sold 22,500 shares of the firm's stock in a transaction that occurred on Monday, October 27th. The shares were so
Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb
10:57am, Monday, 20'th Oct 2025
Activist investor Jana Partners has reportedly taken a stake in The Cooper Companies (NASDAQ:COO) and is pressing the medical-device maker to evaluate strategic alternatives — including a potential
Activist investor Jana Partners takes stake in medical device maker Cooper Companies, WSJ says
08:56am, Monday, 20'th Oct 2025
The hedge fund will push Cooper to improve how it allocates capital in order to boost returns, the WSJ said.
Activist Jana Takes Stake in Cooper, a Maker of Medical Devices
08:00pm, Sunday, 19'th Oct 2025
Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.
The Cooper Companies: Defensive Gem With Insider Buying And Building Momentum
04:17am, Saturday, 18'th Oct 2025
Cooper Companies may strongly outperform the S&P 500 going forward, especially in a recessionary environment, rebounding from 2025's sell-off. COO trades at decade-low enterprise valuations, with rene
The Cooper Companies (COO) Up 3.6% Since Last Earnings Report: Can It Continue?
12:31pm, Friday, 26'th Sep 2025
The Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock?
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
10:51am, Monday, 22'nd Sep 2025
COO's premium lens strategy, MiSight myopia leadership, and fertility portfolio fuel long-term growth despite near-term headwinds.
CooperCompanies Announces Expanded Share Repurchase Program
04:15pm, Wednesday, 17'th Sep 2025
SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase
Here's Why The Cooper Companies (COO) is a Strong Value Stock
10:41am, Monday, 15'th Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Cooper Companies, Inc. (COO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
06:26pm, Wednesday, 03'rd Sep 2025
The Cooper Companies, Inc. (NASDAQ:COO ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 3:00 PM EDT Company Participants Albert White - President, CEO & Non-Independent Director
Interpreting The Cooper Companies (COO) International Revenue Trends
10:15am, Monday, 01'st Sep 2025
Explore how The Cooper Companies' (COO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
